Meet Thermo Fisher Scientific at the
2024 World Conference on Lung Cancer

NGS biomarker results
in 24 hours

Visit us at Booth 2818 to learn how rapid NGS solutions can deliver results in as little as 24 hours. 

Our team will be here to partner with you to find the right tools and services you need. 

 

Industry Symposium

Accelerating Treatment Initiation with Next-Day NGS: Insights from a Multidisciplinary Collaboration Program in Precision Oncology

Sunday, September 8, 2024 | 6:30 PM PDT

Room 33ABC

Personalized medicine offer promising opportunities for cancer patients, yet challenges in implementing biomarker testing into clinical care hinder its potential. Optimal treatment in metastatic NSCLC requires timely access to targeted therapies, which are contingent upon accurate and timely diagnostic testing.

Join us for a session that explores how the successful multidisciplinary integration of radiology, pathology, and pharmacy, leveraging next-day NGS, accelerates access to treatment.

 

Add to Outlook Calendar

 

Agenda

Welcome and introductions

Fernando Lopez-Rios

 

Molecular testing for NSCLC: Importance of expedited testing

Ibiayi Dagogo-Jack

 

Molecular testing for NSCLC: Rapid tissue-based NGS

Charlotte Wang

 

Q&A and panel discussion

All speakers, moderated by Fernando Lopez-Rios

 

Closing remarks

Fernando Lopez-Rios

Biopharma Partnering

Our companion diagnostics team will be available to discuss how rapid, decentralized, next-generation sequencing can accelerate your projects.

 

Visit oncomine.com/pharma for more information.

To request a meeting, contact companiondx@thermofisher.com